Trident Lifeline has received approval for the proposal to subscribe 51% i.e. 5100 equity shares of Rs 10 each of the proposed Company TLL Parenterals which is under process of incorporation. This acquisition would allow the company to partner with the leading and fast-growing market of organic and inorganic chemicals along with pharmaceuticals and allied products. The Board of Directors of the Company at its meeting held on December 11, 2023 has considered and approved the same.
Trident Lifeline is engaged in the manufacturing and marketing of quality finished dosages.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: